← All trials
NCT06255366
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 28, 2024
- Primary completion
- Dec 30, 2024
- Completion date
- Jun 29, 2025
- First posted
- Feb 13, 2024
- Last posted
- Mar 15, 2024
- Enrollment
- 126
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chengdu University of Traditional Chinese MedicinesLead sponsor
- Chengdu University of Traditional Chinese MedicinesSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.